Bill

Bill > HR329


LA HR329

LA HR329
Urges the attorney general and the Louisiana Department of Insurance to investigate pharmacy benefit managers (PBMs) for potential violations of law and to urge and request the legislature to pass legislation prohibiting PBMs from owning or having a financial interest in pharmacies in this state


summary

Introduced
06/08/2025
In Committee
Crossed Over
Passed
06/10/2025
Dead
Signed/Enacted/Adopted
06/11/2025

Introduced Session

2025 Regular Session

Bill Summary

A RESOLUTION To urge and request the attorney general and the Louisiana Department of Insurance to investigate pharmacy benefit managers (PBMs) for potential violations of law and to urge and request the legislature to pass legislation prohibiting PBMs from owning or having a financial interest in pharmacies in this state.

AI Summary

This resolution urges the Louisiana attorney general and the Department of Insurance to investigate pharmacy benefit managers (PBMs), which are intermediary companies that manage prescription drug benefits for insurance providers. The resolution highlights concerns about PBMs' market practices, including their ability to own pharmacies and potentially manipulate drug pricing and reimbursement rates. Specifically, the resolution calls for an investigation into PBMs' compliance with existing laws and requests legislative action to prohibit PBMs from owning or controlling pharmacies in the state. The resolution is motivated by evidence from other states showing that PBMs can create competitive disadvantages for independent pharmacies, potentially increase prescription drug costs, and reduce patient access to care. The document notes that PBMs now process 80% of all prescriptions in the United States and control 70% of specialty drug revenues, which has contributed to the closure of approximately 10% of rural independent pharmacies nationwide. By transmitting this resolution to key state officials, the Louisiana House of Representatives aims to draw attention to these issues and promote more transparent and fair pharmaceutical practices.

Sponsors (37)

Dustin Miller (D)* Roy Adams (D),  Beryl Amedée (R),  Michael Bayham (R),  Stephanie Berault (R),  Beth Billings (R),  Delisha Boyd (D),  Rhonda Butler (R),  Robby Carter (D),  Michael Echols (R),  Peter Egan (R),  Aimee Freeman (D),  Barbara Freiberg (R),  Brian Glorioso (R),  Dodie Horton (R),  Jason Hughes (D),  Edmond Jordan (D),  Alonzo Knox (D),  Jeremy LaCombe (R),  Ed Larvadain (D),  Rodney Lyons (D),  Denise Marcelle (D),  Jack McFarland (R),  Dixon McMakin (R),  Pat Moore (D),  Candace Newell (D),  Chuck Owen (R),  Tammy Phelps (D),  Rodney Schamerhorn (R),  Annie Spell (R),  Sylvia Taylor (D),  Francis Thompson (R),  Joy Walters (D),  Roger Wilder (R),  Jeffrey Wiley (R),  John Wyble (R),  Rashid Young (D), 

Last Action

Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House. (on 06/11/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...